Klinische und genetische Studien

Derzeit ist das Institut für Systemische Motorikforschung an folgenden klinischen Studien beteiligt:

1. Der von der DFG geförderten Studie "Randomized double-blind placebo controlled trial to demonstrate the efficacy and safety of nabiximols in the treatment of adults with chronic tic disorders ("CANNA-TICS")" unter Federführung der Klinik für Psychiatrie, Sozialpsychiatrie und Psychotherapie, Medizinische Hochschule Hannover (Professor Müller-Vahl)

2. TicGenetics: Genetic study to identify the genetic factors of Tourette syndrome

3. Enroll-HD: A Prospective Registry Study in a Global Huntington’s Disease Cohort – a CHDI Foundation Project

4. ASO-Roche: A randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of intrathecal administered RO7234292 in Participants with manifest Huntington´s Disease

5. Pattern: Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury (PATTERN), NCT03992404

6. Abolish: Study to Assess the Effectiveness of AboBoNT-A Injections for Adult Lower Limb Spasticity in a Real Life Cohort (AboLiSh), NCT04050527